VALENCIA, Calif., Oct. 12, 2017 /PRNewswire/ -- Bioness, Inc., the leading provider of cutting edge, clinically supported rehabilitation therapies, today announced it is exhibiting at the American Academy of Physical Medicine and Rehabilitation (AAPM&R) Annual Assembly. The assembly begins today, October 12th, and runs through October 15th, 2017 in Denver, Colorado. Attendees have the opportunity to experience Bioness implantable and external neuromodulation systems, robotic systems and software based therapy programs at booth #1006.
Bioness is showcasing the StimRouter Neuromodulation System®, a minimally invasive, surgical device designed to treat chronic peripheral nerve pain. The StimRouter targets pain at the point of origin, minimizes long-term healthcare costs and may provide pain relief when other treatments, such as medications and injections, have limited effect.1 The StimRouter has been implanted at 20+ different peripheral nerves, with the most common being the axillary nerve, located in the shoulder. Shoulder pain is one of the most common complications following a stroke which is primarily treated by healthcare professionals specializing in physical medicine and rehabilitation.
Attending Physiatrists and other attendees have the opportunity to see additional innovative solutions – specifically, the L300 Go System. The L300 Go addresses the limitations of lower limb paralysis following an upper motor neuron injury. The L300 Go follows the success of the original L300 and L300 Plus systems, offering significant new features including 3D motion detection of gait events, multi-channel capability, activity tracking via mobile iOS application and new electrode options.
In addition to the StimRouter Neuromodulation System and L300 Go System, attendees can also experience the following Bioness technologies:
To see these solutions for yourself, visit us at AAPM&R at booth #1006.
About Bioness, Inc.
Bioness is the leading provider of innovative technologies helping people regain mobility and independence. Bioness solutions include implantable and external neuromodulation systems, robotic systems and software based therapy programs providing functional and therapeutic benefits for individuals affected by pain, central nervous system disorders and orthopedic injuries. Currently, Bioness offers six medical devices within its commercial portfolio which are distributed and sold on five continents and in over 50 countries worldwide. Our technologies have been implemented in the most prestigious and well-respected institutions around the globe with approximately 90% of the top rehabilitation hospitals in the United States currently using one or more Bioness solutions. Bioness has a singular focus on aiding large, underserved customer groups with innovative, evidence-based solutions and we will continue to develop and make commercially available new products that address the growing and changing needs of our customers. Individual results vary. Consult with a qualified physician to determine if this product is right for you. Contraindications, adverse reactions and precautions are available online at www.bioness.com.
Media Relations Contact Information
Next Step Communications
Bioness®, BITS®, H200®, L300 Go™, StimRouter® and Vector Gait and Safety System® are trademarks of Bioness, Inc. | www.bioness.com | Rx Only for applicable products |
1 Deer T, et al. 2016. Neuromodulation. 19:91-100.
SOURCE Bioness, Inc.